MSF teams care for people living with diabetes in many countries where we work, in Lebanon, Iraq, South Sudan, DRC, and others. Many projects are set-up to respond to patients presenting with ketoacidosis, due to a lack of insulin treatment - and insulin access.
https://twitter.com/MSF_canada/status/1382331667705163776
The way in which the big 3 insulin makers monopolize the insulin market is unbelievable, really. It's a racket. They've raised their prices in lockstep with each other for years, to the point that people are dying because they can't afford them anymore. nytimes.com/2016/02/21/opi…
Companies are further monopolizing the insulin market by layering patents on new delivery devices (insulin pens) that make it difficult for lower-cost generics to come on the market. Device patents add >9 years' additional patent protection on some pens: journals.plos.org/plosone/articl…
There are great advocates pushing to improve access to affordable insulin and comprehensive diabetes care (it's not just insulin, it's also supplies: glucometers, strips, syringes, needles, pumps). Shout out to @t1international & the many #insulinforall advocates out there.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
